No connection

Search Results

Analysis Neutral

AC Immune rises after amending licensing deal with Lilly

Apr 07, 2026 14:45 UTC

AC Immune rises after amending licensing deal with Lilly.

  • shingopix/iStock via Getty Images AC Immune (ACIU) traded higher on Tuesday after the Swiss biotech announced an amendment to a license and collaboration agreement signed with Eli Lilly (LLY) in 2018 to develop a new class of neurology therapies known as Morphomer Tau
  • Under

shingopix/iStock via Getty Images AC Immune (ACIU) traded higher on Tuesday after the Swiss biotech announced an amendment to a license and collaboration agreement signed with Eli Lilly (LLY) in 2018 to develop a new class of neurology therapies known as Morphomer Tau. Under

Sign up free to read the full analysis

Create a free account to unlock full AI-curated market articles, personalized alerts, and more.

Create Free Account Already have an account? Sign In
Share this article

Stay Ahead of the Markets

Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.

Get Started Free View Plans
Features Terminal AI Assistant Analysis Market News Pricing
Start Trading with AI Already have an account? Sign In
Home
Terminal
AI
Markets
Profile